Related Experiment Videos

Deep learning for cardiovascular disease: a comprehensive review of detection and risk forecasting

N Ganeshan1, G Magesh1

  • 1School of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, India.

Insights

Deep learning models integrating multimodal data significantly improve cardiovascular disease (CVD) early detection and risk assessment. These advanced AI approaches achieve high accuracy, offering personalized recommendations for better clinical practice and prevention.

Area of Science:

  • Artificial Intelligence in Medicine
  • Cardiovascular Disease Research
  • Deep Learning Algorithms

Background:

  • Cardiovascular disease (CVD) is a leading global health threat, necessitating improved risk analysis for clinical practice and prevention.
  • Emerging data modalities like wearable sensors, EHRs, and genomics enable holistic CVD risk assessment via multimodal data integration.

Purpose of the Study:

  • To systematically review and analyze deep learning algorithms using multimodal data for early CVD detection and risk stratification.
  • To characterize diverse data streams and deep learning fusion methods applied in CVD risk assessment.

Main Methods:

  • Systematic review following PRISMA 2020 guidelines, analyzing 69 studies.
  • Characterization of data streams including physiological, imaging, EHR, and genomic data.
  • Analysis of deep neural networks (CNNs, RNNs, BiGRU, CNN-LSTM) with various fusion techniques (early, late, attention-based).

Main Results:

  • Deep learning models demonstrate dramatic improvements in predictive accuracy (often >98%) for CVD risk.
  • Models show enhanced robustness to missing or noisy data and enable real-time, individualized recommendations.
  • Top models like DEEP-CARDIO BiGRU-Attention achieved 99.9% accuracy; federated FL-LSTM reached 99% AUC with privacy protection.

Conclusions:

  • Multimodal deep learning offers a powerful paradigm shift for early CVD detection and personalized risk assessment.
  • Explainable AI methods (Grad-CAM, SHAP) are crucial for understanding model predictions in imaging and structured data.
  • Future directions include systematic reproducibility, federated learning, equitable AI, and regulatory translation for clinical implementation.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...